Prevalence and incidence of uveitis in patients with Spondyloarthritis: the impact of the biologics era. Data from the international ASAS-COMOSPA study (2025)
https://pubmed.ncbi.nlm.nih.gov/39361425

Trends to shorter diagnostic delay in Spondyloarthritis patients during the last decades and association with clinical presentation: data from ASAS-COMOSPA study (2025)
https://pubmed.ncbi.nlm.nih.gov/39890204

Access, Effectiveness, Safety, and Survival of Secukinumab in Patients With Axial Spondyloarthritis and Axial Psoriatic Arthritis: A Real-World Study in Argentina (2025)
https://pubmed.ncbi.nlm.nih.gov/40374511

ASAS consensus definition of early axial spondyloarthritis (2024)
https://pubmed.ncbi.nlm.nih.gov/37321799

Prevalence and distribution of peripheral musculoskeletal manifestations in spondyloarthritis including psoriatic arthritis: results of the worldwide, cross-sectional ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/33462157/

Identificación of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study (2021)
https://pubmed.ncbi.nlm.nih.gov/34750246/

Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort (2016)
https://pubmed.ncbi.nlm.nih.gov/28002334/

Secukinumab: a promising therapeutic option in spondyloarthritis (2016)
https://pubmed.ncbi.nlm.nih.gov/27437696/

Rheumatic manifestations in inflammatory bowel diseases: a link between GI and rheumatology (2016)
https://pubmed.ncbi.nlm.nih.gov/26573206/